Replies to post #16 on Wright Medical Group, Inc. CVR (WMGIZ)

[fredman]

The sales milestones are based upon "All products contributed by Biomimetic", not just sales of Augment. These revenue milestones will undoubtedly be achieved, imo. The CVR's will more than likely see $3.00 once the Biomimetic Sales milestones are met, imo. $6.50 with FDA approval of Augment.

$1.50 per share upon the achievement of $40 million in trailing twelve month sales for all products contributed by BioMimetic;
$1.50 per share upon the achievement of $70 million in trailing twelve month sales for all products contributed by BioMimetic.

Source: http://phx.corporate-ir.net/phoenix.zhtml?c=129751&p=irol-newsArticle&ID=1760038&highlight=